These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8842414)

  • 1. Blockade of N- and Q-type Ca2+ channels inhibit K(+)-evoked [3H]acetylcholine release in rat hippocampal slices.
    Saydoff JA; Zaczek R
    Brain Res Bull; 1996; 40(4):283-6. PubMed ID: 8842414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum.
    Dobrev D; Milde AS; Andreas K; Ravens U
    Br J Pharmacol; 1999 May; 127(2):576-82. PubMed ID: 10385261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of subtype-specific Ca(2+)-antagonists and Ca(2+)-free media on the field stimulation-evoked release of ATP and [3H]acetylcholine from rat habenula slices.
    Sperlágh B; András I; Vizi S
    Neurochem Res; 1997 Aug; 22(8):967-75. PubMed ID: 9239752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of potassium-evoked [3H]dopamine release from rat striatal slices by voltage-activated calcium channel ligands: effects of omega-conotoxin-MVIIC.
    Dobrev D; Andreas K
    Neurochem Res; 1997 Sep; 22(9):1085-93. PubMed ID: 9251097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-, N- and T- but neither P- nor Q-type Ca2+ channels control vasopressin-induced Ca2+ influx in magnocellular vasopressin neurones isolated from the rat supraoptic nucleus.
    Sabatier N; Richard P; Dayanithi G
    J Physiol; 1997 Sep; 503 ( Pt 2)(Pt 2):253-68. PubMed ID: 9306270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Na+-channels by neurotoxins produces different effects on [3H]ACh release with mobilization of distinct Ca2+-channels.
    Falqueto EB; Massensini AR; Moraes-Santos T; Gomez MV; Romano-Silva MA
    Cell Mol Neurobiol; 2002 Dec; 22(5-6):819-26. PubMed ID: 12585699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of invertebrate peptide toxins to establish Ca2+ channel identity of CA3-CA1 neurotransmission in rat hippocampal slices.
    Nooney JM; Lodge D
    Eur J Pharmacol; 1996 Jun; 306(1-3):41-50. PubMed ID: 8813613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission.
    Wright CE; Angus JA
    Br J Pharmacol; 1996 Sep; 119(1):49-56. PubMed ID: 8872356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-activated calcium channels involved in veratridine-evoked [3H]dopamine release in rat striatal slices.
    Dobrev D; Milde AS; Andreas K; Ravens U
    Neuropharmacology; 1998 Aug; 37(8):973-82. PubMed ID: 9833626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of the voltage-gated calcium channels mediating dopamine and acetylcholine release from the isolated rat retina.
    Tamura N; Yokotani K; Okuma Y; Okada M; Ueno H; Osumi Y
    Brain Res; 1995 Apr; 676(2):363-70. PubMed ID: 7614007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release.
    Waldmeier PC; Wicki P; Fröstl W; Bittiger H; Feldtrauer JJ; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):670-8. PubMed ID: 9053740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum.
    Dobrev D; Ravens U
    Eur J Pharmacol; 2003 Feb; 461(2-3):105-11. PubMed ID: 12586205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of acetylcholine release from presynaptic terminals of skate electric organ by calcium channel antagonists: a detailed pharmacological study.
    Richardson CM; Dowdall MJ; Bowman D
    Neuropharmacology; 1996; 35(11):1537-46. PubMed ID: 9025101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of different calcium channels in K+- and veratridine-induced increases of cytosolic calcium concentration in rat cerebral cortical synaptosomes.
    Meder W; Fink K; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):797-805. PubMed ID: 9453466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
    Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
    Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Na+,K+-ATPase by ouabain opens calcium channels coupled to acetylcholine release in guinea pig myenteric plexus.
    Gomez RS; Gomez MV; Prado MA
    J Neurochem; 1996 Apr; 66(4):1440-7. PubMed ID: 8627296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-threshold Ca2+ currents in rat hippocampal interneurones and their selective inhibition by activation of GABA(B) receptors.
    Lambert NA; Wilson WA
    J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):115-27. PubMed ID: 8730588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative actions of synthetic omega-grammotoxin SIA and synthetic omega-Aga-IVA on neuronal calcium entry and evoked release of neurotransmitters in vitro and in vivo.
    Keith RA; Mangano TJ; Lampe RA; DeFeo PA; Hyde MJ; Donzanti BA
    Neuropharmacology; 1995 Nov; 34(11):1515-28. PubMed ID: 8606798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct effects of omega-toxins and various groups of Ca(2+)-entry inhibitors on nicotinic acetylcholine receptor and Ca2+ channels of chromaffin cells.
    Villarroya M; De la Fuente MT; López MG; Gandía L; García AG
    Eur J Pharmacol; 1997 Feb; 320(2-3):249-57. PubMed ID: 9059861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl-4-phenylpyridinium (MPP(+))-evoked dopamine release from rat striatal slices: possible roles of voltage-dependent calcium channels and reverse dopamine transport.
    Inazu M; Kubota N; Takeda H; Oguchi K; Koizumi M; Kimura S; Matsumiya T
    Neurochem Int; 2001 Sep; 39(3):253-60. PubMed ID: 11434982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.